Nerve growth factor and basic fibroblast growth factor promote reinnervation by nerve-muscle-endplate grafting

Muscle Nerve. 2018 Mar;57(3):449-459. doi: 10.1002/mus.25726. Epub 2017 Jul 7.

Abstract

Introduction: This study was designed to test whether exogenous application of nerve growth factor (NGF) and basic fibroblast growth factor (FGF-2) to muscles reinnervated with nerve-muscle-endplate band grafting (NMEG) could promote specific outcomes.

Methods: The right sternomastoid muscle in adult rats was experimentally denervated and immediately reinnervated by implanting an NMEG pedicle from the ipsilateral sternohyoid muscle. A fibrin sealant containing NGF and FGF-2 was focally applied to the implantation site. Maximal tetanic force, muscle weight, regenerated axons, and motor endplates were analyzed 3 months after treatment.

Results: Mean tetanic force, wet muscle weight, and number of regenerated axons in the treated muscles were 91%, 92%, and 84% of the contralateral controls, respectively. The majority of endplates (86%) in the treated muscles were reinnervated by regenerated axons.

Discussion: Focal administration of NGF and FGF-2 promotes efficacy of the NMEG technique. Muscle Nerve 57: 449-459, 2018.

Keywords: basic fibroblast growth factor; muscle reinnervation; native motor zone; nerve growth factor; nerve−muscle−endplate grafting.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Female
  • Fibroblast Growth Factor 2 / pharmacology*
  • Motor Endplate / drug effects*
  • Motor Endplate / physiology
  • Muscle Denervation
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / innervation
  • Nerve Growth Factor / pharmacology*
  • Nerve Regeneration / drug effects*
  • Nerve Regeneration / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function / drug effects*
  • Recovery of Function / physiology

Substances

  • Fibroblast Growth Factor 2
  • Nerve Growth Factor